Bmax | Kd | Bhigh | Blow | |
---|---|---|---|---|
fmol/mg | nM | % | % | |
Control | 643 ± 64 | 1.5 ± 0.2 | 33 ± 4 | 67 ± 4 |
Lesioned | 651 ± 43 | 1.6 ± 0.2 | 49 ± 31-150 | 51 ± 31-150 |
D1 dopamine receptor binding was assessed in membranes prepared from control and lesioned striata using the selective D1dopamine receptor antagonist [3H]SCH23390 as ligand. For saturation binding, striatal membranes were incubated at 37°C for 30 min with increasing concentrations of [3H]SCH23390 (0.1–6.4 nM) and terminated by vacuum filtration through Whatman GF/B filters. Nonspecific binding was defined as binding in the presence of 10 μMcis-flupenthixol. To prevent nonspecific association of [3H]SCH23390 with serotonin receptors, 10 μM mesulergine was added to the assay mixture. Maximal binding (Bmax) and binding affinity (Kd) were calculated by Scatchard analysis of specific [3H]SCH23390 binding. For competition experiment, [3H]SCH23390 (1 nM) binding was carried out in the presence of 10−10 to 10−4 M dopamine (eight concentrations in 10-fold increments). The dopamine-mediated competition curve was fitted and the percentage of high- (Bhigh) and low- (Blow) affinity binding sites were calculated according to a two-site binding model (Munson and Rodbard, 1980). Data are presented as mean ± S.E.M. derived from four individual experiments each performed in duplicate.
↵1-150 p < 0.05 compared with respective values of control group by two-tailed Student's t test.